Expand your knowledge.

Diabetes & Fatty Liver Disease: What Every Liver Specialist Should Know

August 22, 2023, 2PM PT

Join Key Opinion Leader and renowned endocrinologist Dr. Kenneth Cusi for an informative webinar that will unpack the relationship between diabetes and fatty liver disease.

Key Points to be covered:

  • Why is the incidence of NASH/NAFLD so high in patients with diabetes mellitus?
  • How to determine patients at risk of disease progression
  • Inherent challenges managing concurrent obesity, diabetes and NASH
  • How to treat NASH today with GLP-1 receptor agonists and pioglitazone
  • Future obesity and diabetes treatments for NASH

Featured Speaker(s):

Kenneth Cusi, MD

Dr. Kenneth Cusi is a Professor of Medicine in the Division of Endocrinology, Diabetes & Metabolism in the Department of Medicine at the University of Florida. Previously, Dr. Cusi was a faculty member for more than 15 years at the Diabetes Division of the University of Texas Health Science Center at San Antonio (UTHSCSA) and the Veterans Health Administration System; one of the country’s leading diabetes programs. He is a nationally and internationally recognized investigator and speaker on the impact of non-alcoholic fatty liver disease (NAFLD). He is the principal investigator in numerous NIH grants, investigator-initiated, and multi-center industry-sponsored studies in the areas of obesity, type 2 diabetes mellitus and NAFLD. Dr. Cusi has published over 250 original articles, editorials, reviews and book chapters on obesity, diabetes and liver disease.

Michael Betel

Michael Betel


Michael Betel is the President and Founder of the Fatty Liver Alliance, a charity focused on the early detection, prevention, and treatment of NAFLD and NASH. He has been a leader in the area of liver disease, in both commercial and not-for-profit organizations for over 25 years, as a Director at Hoffmann-La Roche and Canadian Blood Services, and as a sales and marketing leader at Schering-Plough. He was a Director on the board of a national liver-focused health charity for 9 years. He is currently the Chair of the Global Liver Institute’s Liver Action Network, which includes 12 community liver advocacy organizations.

Share With Your Network